Abstract

AimTo investigate whether Roux-en-Y gastric bypass surgery (RYGB) – an in vivo model for normalisation of hyperglycaemia – improves carotid intima-media thickness (IMT) in patients with type 2 diabetes (T2D)/impaired glucose tolerance (IGT) and normal glucose tolerance (NGT). MethodsObservational prospective study, 34 obese patients (T2D (n=14)/IGT (n=4), and NGT (n=16)) were investigated before and six and 12months after RYGB. ResultsMean carotid IMT was significantly reduced 12months after RYGB in patients with T2D/IGT (−0.041mm (95% CI −0.069; −0.012, p=0.005)) but not in patients with NGT (−0.010mm (−0.039; 0.020, p=0.52)). The between-group difference was not significant (p=0.13). Twelve months after RYGB, patients with respectively T2D/IGT and NGT demonstrated changes in weight: −29.9kg, p<0.001/−30.6kg, p<0.001, HbA1c: −0.7%, p<0.001/−0.1%, p=0.33, systolic blood pressure: −2mmHg, p=0.68/−10mmHg, p=0.01 and diastolic blood pressure: −8mmHg, p=0.003/−11mmHg, p<0.001. 80% of T2D patients terminated antihyperglycaemic medication. ConclusionMean carotid IMT was significantly reduced 12months after RYGB in patients with T2D/IGT which provides evidence to support that the earliest atherosclerotic changes in the arterial wall are reversible. Although numerically different from the changes observed in patients with NGT, the between-group difference was not statistically significant.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call